Shilpa Puli

Effect of Combination Treatment of Rapamycin and Isoflavones on mTOR Pathway in Human Glioblastoma (U87) Cells

Shilpa Puli, Aditi Jain, J. Lai, 2010, Neurochemical Research.

Privigen® has similar pharmacokinetic properties in primary and secondary immune deficiency

Shilpa Puli, M. Tortorici, J. Lawo, 2019, International immunopharmacology.

Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) Cells by isoflavones

Shilpa Puli, A. Bhushan, J. Lai, 2006, Journal of Neuro-Oncology.

Signaling Pathways Mediating Manganese-Induced Toxicity in Human Glioblastoma Cells (U87)

Shilpa Puli, J. Lai, A. Bhushan, 2006, Neurochemical Research.